Home Coronavirus
coronavirus
The second part of our A-Z looks at financing, growth, healthtech, infectious diseases, joint ownership and KOLs.
The fourth part of our A-Z looks at quality of care, R&D, scalability, tie-ups and universal healthcare.
From wearable devices and telemedicine to gene therapy and clinical trials, technology is transforming every aspect of healthcare, says Silvia Oteri, partner and head of healthcare at Permira.
The third part of our A-Z looks at logistics, mental health, nursing homes, outcomes and pharmaceuticals.
The global pandemic has accelerated demand for everything from diagnostics to mental healthcare. But long-term growth trends are also intact, say Glenn Mincey and Kristin Pothier of KPMG.
The pandemic has brought new impetus to one of private equity’s most dynamic sectors.
In the final part of our A-Z we look at visualisation, wellbeing, X-rays and diagnostics, youth services and Zoom healthcare.
Whether it is the partnerships needed to develop vaccines or the remarkable strides made by telemedicine, there’s a growing appreciation that the health sector represents a dynamic source of deal opportunities.
In the first part of our A-Z, we examine ancillary healthcare, biotech, covid-19, digitisation and eldercare.
PEI was curious to learn how the private equity community was navigating the complex, and mentally draining, world of business travel.